Comparison of ProGlide vs. Prostar in patients undergoing transcatheter aortic valve implantation.

CONCLUSIONS: Use of ProGlide and Prostar as VCD of choice for TAVI appears similarly safe and effective, despite some potential benefits associated with Proglide. Further randomized trials are warranted to confirm or disprove these findings. PMID: 31670491 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31670491?dopt=Abstract

Source: Minerva Cardioangiologica - November 2, 2019 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research